Monday November 23 2009 | Biotechnology feed | All feeds
|
|
DMI BioSciences, Inc.
Download detailed PDF Members: DMI BioSciences, Inc. is a privately-held biopharmaceutical company that discovers and develops small molecule and peptide-based pharmaceuticals and biomarkers for acute and chronic inflammation. DMI focuses on immunologic, vascular and CNS diseases, including acute coronary syndrome, multiple sclerosis, Alzheimer's disease, asthma and cancer. DMI is co-developing several of its drug candidates with industry partners. Two of DMI's drug candidates are currently in human clinical trials. DMI's strategy is to develop pharmaceutical compounds and biomarkers through preclinical and early-stage clinical development and collaborate with financial and industry partners for later-stage development and commercialization.
This page has been viewed 549 times since April 2007, the link to the organisation's website has been followed 114 times Recent Search Terms used to find this page: dmi drug | dmi biosciences | dmi biosciences | dmi biosciences | DMI Bio | DMI Biosciences | dmi biosciences | dmi biosciences | premature ejaculation results from DMI Bioscience | . Search for more companies in Englewood Search for more companies in Colorado This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for DMI BioSciences, Inc. | ||||||||||||||||||||||||||||||||||||||
|